Skip to content

Assessment of Lotrafilcon A Contact Lenses

Assessment of Lotrafilcon A Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01185834
Enrollment
118
Registered
2010-08-20
Start date
2010-07-31
Completion date
2010-12-31
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this 3-month study is to evaluate subjective responses to an upgraded contact lens.

Interventions

DEVICELotrafilcon A upgrade soft contact lens

Silicone hydrogel contact lens approved for daily wear and extended wear up to 30 consecutive nights.

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have normal ocular findings. * Be able to wear the study lenses in the available powers. * Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day. * Wear Night & Day contact lenses. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Require concurrent ocular medication. * Eye injury or surgery within twelve weeks prior to enrollment. * Currently enrolled in an ophthalmic clinical trial. * Any active corneal infection. * Corneal refractive surgery. * Wear AIR OPTIX NIGHT & DAY AQUA lenses. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Overall Comfort3 months of wear, replacing lenses monthlyAs interpreted by the participant and recorded on a questionnaire as a single, retrospective evaluation of 3 months of wear time. Overall comfort was evaluated binocularly and rated on a 10-point scale, with 1 being poor and 10 being excellent.

Secondary

MeasureTime frameDescription
Overall Lens Fit3 months of wear, replacing lenses monthlyAs assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye. Lens fit was graded by eye on a 5-point scale, with 2=unacceptably loose, 1=acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight

Participant flow

Recruitment details

Thirteen US optometry sites recruited and enrolled subjects for this study.

Participants by arm

ArmCount
Lotrafilcon A
Lotrafilcon A lenses worn for 3 months, replaced monthly. Lenses worn on the same basis as habitual lenses, as prescribed by eye care practitioner (e.g., daily wear, flexible wear, extended wear up to 30 continuous nights).
118
Total118

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyBiomicroscopy4
Overall StudyDiscomfort4
Overall StudyEarly exit - Site error2
Overall StudyLost to Follow-up2
Overall StudyTime/Job Conflict2

Baseline characteristics

CharacteristicLotrafilcon A
Age Continuous34.1 years
STANDARD_DEVIATION 10.3
Sex: Female, Male
Female
84 Participants
Sex: Female, Male
Male
34 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 118
serious
Total, serious adverse events
0 / 118

Outcome results

Primary

Overall Comfort

As interpreted by the participant and recorded on a questionnaire as a single, retrospective evaluation of 3 months of wear time. Overall comfort was evaluated binocularly and rated on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: 3 months of wear, replacing lenses monthly

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon AOverall Comfort8.4 units on a scaleStandard Deviation 1.6
Secondary

Overall Lens Fit

As assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye. Lens fit was graded by eye on a 5-point scale, with 2=unacceptably loose, 1=acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight

Time frame: 3 months of wear, replacing lenses monthly

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon AOverall Lens Fit0.0 units on a scaleStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026